Return On Assets of LUMOS PHARMA, INC. from 30 Jun 2012 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
LUMOS PHARMA, INC. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2012 to 30 Sep 2024.
  • LUMOS PHARMA, INC. Return On Assets for the quarter ending 30 Sep 2024 was -130%, a 138% decline year-over-year.
  • LUMOS PHARMA, INC. annual Return On Assets for 2023 was -65%, a 73% decline from 2022.
  • LUMOS PHARMA, INC. annual Return On Assets for 2022 was -38%, a 36% decline from 2021.
  • LUMOS PHARMA, INC. annual Return On Assets for 2021 was -28%, a 656% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

LUMOS PHARMA, INC. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 -130% -75% -138% 01 Jul 2024 30 Sep 2024
Q2 2024 -104% -57% -122% 01 Apr 2024 30 Jun 2024
Q1 2024 -86% -45% -110% 01 Jan 2024 31 Mar 2024
Q4 2023 -65% -28% -73% 01 Oct 2023 31 Dec 2023
Q3 2023 -55% -23% -72% 01 Jul 2023 30 Sep 2023
Q2 2023 -47% -17% -57% 01 Apr 2023 30 Jun 2023
Q1 2023 -41% -12% -43% 01 Jan 2023 31 Mar 2023
Q4 2022 -38% -10% -36% 01 Oct 2022 31 Dec 2022
Q3 2022 -32% -9% -37% 01 Jul 2022 30 Sep 2022
Q2 2022 -30% -15% -107% 01 Apr 2022 30 Jun 2022
Q1 2022 -29% -18% -171% 01 Jan 2022 31 Mar 2022
Q4 2021 -28% -24% -656% 01 Oct 2021 31 Dec 2021
Q3 2021 -23% -14% -150% 01 Jul 2021 30 Sep 2021
Q2 2021 -14% -1% -5.3% 01 Apr 2021 30 Jun 2021
Q1 2021 -11% +2% +17% 01 Jan 2021 31 Mar 2021
Q4 2020 -4% +14% +79% 01 Oct 2020 31 Dec 2020
Q3 2020 -9% +5% +37% 01 Jul 2020 30 Sep 2020
Q2 2020 -14% +4% +22% 01 Apr 2020 30 Jun 2020
Q1 2020 -13% +15% +54% 01 Jan 2020 31 Mar 2020
Q4 2019 -17% +20% +53% 01 Oct 2019 31 Dec 2019
Q3 2019 -15% +21% +59% 01 Jul 2019 30 Sep 2019
Q2 2019 -17% +27% +61% 01 Apr 2019 30 Jun 2019
Q1 2019 -27% +17% +39% 01 Jan 2019 31 Mar 2019
Q4 2018 -37% +11% +23% 01 Oct 2018 31 Dec 2018
Q3 2018 -36% +12% +25% 01 Jul 2018 30 Sep 2018
Q2 2018 -44% -3% -7.1% 01 Apr 2018 30 Jun 2018
Q1 2018 -45% +3% +6.5% 01 Jan 2018 31 Mar 2018
Q4 2017 -47% -1% -3.2% 01 Oct 2017 31 Dec 2017
Q3 2017 -48% 0% -0.59% 01 Jul 2017 30 Sep 2017
Q2 2017 -41% +4% +9.1% 01 Apr 2017 30 Jun 2017
Q1 2017 -48% -14% -41% 01 Jan 2017 31 Mar 2017
Q4 2016 -46% -29% -170% 01 Oct 2016 31 Dec 2016
Q3 2016 -48% -90% -213% 01 Jul 2016 30 Sep 2016
Q2 2016 -45% -100% -183% 01 Apr 2016 30 Jun 2016
Q1 2016 -34% -104% -148% 01 Jan 2016 31 Mar 2016
Q4 2015 -17% -95% -122% 01 Oct 2015 31 Dec 2015
Q3 2015 42% +81% 01 Jul 2015 30 Sep 2015
Q2 2015 54% +99% 01 Apr 2015 30 Jun 2015
Q1 2015 70% +115% 01 Jan 2015 31 Mar 2015
Q4 2014 78% +124% 01 Oct 2014 31 Dec 2014
Q3 2014 -39% +13% +25% 01 Jul 2014 30 Sep 2014
Q2 2014 -45% +9% +16% 01 Apr 2014 30 Jun 2014
Q1 2014 -45% +16% +26% 01 Jan 2014 31 Mar 2014
Q4 2013 -46% +17% +27% 01 Oct 2013 31 Dec 2013
Q3 2013 -51% +4% +6.4% 01 Jul 2013 30 Sep 2013
Q2 2013 -54% +4% +7.4% 01 Apr 2013 30 Jun 2013
Q1 2013 -60% 01 Jan 2013 31 Mar 2013
Q4 2012 -63% 01 Oct 2012 31 Dec 2012
Q3 2012 -55% 01 Jul 2012 30 Sep 2012
Q2 2012 -58% 01 Apr 2012 30 Jun 2012

LUMOS PHARMA, INC. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2023 -65% -28% -73% 01 Jan 2023 31 Dec 2023
2022 -38% -10% -36% 01 Jan 2022 31 Dec 2022
2021 -28% -24% -656% 01 Jan 2021 31 Dec 2021
2020 -4% +7% +66% 01 Jan 2020 31 Dec 2020
2019 -11% +26% +71% 01 Jan 2019 31 Dec 2019
2018 -37% +11% +23% 01 Jan 2018 31 Dec 2018
2017 -47% -1% -3.2% 01 Jan 2017 31 Dec 2017
2016 -46% -29% -170% 01 Jan 2016 31 Dec 2016
2015 -17% -95% -122% 01 Jan 2015 31 Dec 2015
2014 78% +124% 01 Jan 2014 31 Dec 2014
2013 -46% +17% +27% 01 Jan 2013 31 Dec 2013
2012 -63% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.